CompletedNCT00001258
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 90 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Schizophrenia
SuspendedNCT05046353
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
CompletedNCT05893862
This study exists to better understand the safety of the medication MK-8189 and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication MK-8189 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Merck Sharp & Dohme LLC
- Condition
- Schizophrenia
CompletedNCT02411695
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 13 Years to 17 Years
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- Schizophrenia
CompletedNCT00001486
This study exists to explore whether the medication Schizophrenia could improve care and understanding. Researchers are trying to understand whether the medication Schizophrenia can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Schizophrenia
RecruitingNCT05778591
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
RecruitingNCT01730781
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand what smoking support or smoking-related treatment can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
RecruitingNCT06969755
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- Canada, United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia
RecruitingNCT01409109
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
- Condition
- Schizophrenia
TerminatedNCT05724810
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand what smoking support or smoking-related treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Stony Brook University
- Condition
- Schizophrenia
CompletedNCT05204407
This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
SuspendedNCT05567848
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
- Condition
- Schizophrenia
RecruitingNCT06947941
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Australia, Canada, Japan, United Kingdom, United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
CompletedNCT00004571
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 120 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Schizophrenia
TerminatedNCT05211947
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 51 Years
- Countries
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT00942981
This study exists to see whether the medication NNC-112 can make care clearer and more responsive. Researchers are trying to understand whether the medication NNC-112 can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 90 Years
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH)
- Condition
- Schizophrenia
RecruitingNCT04226898
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Sheppard Pratt Health System
- Condition
- Schizophrenia
TerminatedNCT06155695
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Brian A Coffman, PhD
- Condition
- Schizophrenia
RecruitingNCT04887792
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- India, United States
- Sponsor
- Vishwajit Nimgaonkar, MD PhD
- Condition
- Schizophrenia
SuspendedNCT05259306
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 21 Years to 80 Years
- Countries
- United States
- Sponsor
- NYU Langone Health
- Condition
- Schizophrenia
RecruitingNCT03971487
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United States
- Sponsor
- The Methodist Hospital Research Institute
- Condition
- Schizophrenia
CompletedNCT05345184
This study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- Schizophrenia
CompletedNCT05899348
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT05693935
This study exists to understand whether the medication TV-44749 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication TV-44749 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Bulgaria, China, Romania, Turkey, United States
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Condition
- Schizophrenia
CompletedNCT06627413
This study exists to better understand the safety of this type of care and how manageable it feels in practice. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Intra-Cellular Therapies, Inc.
- Condition
- Schizophrenia